Endocrine Surgery »  Research »  Clinical Trials
 
General Surgery Programs
Dept. of Surgery Websites

Message from the Chief

Quan-Yang Duh, M.D.

Professor & Chief, Section of Endocrine Surgery

Thyroid Cancer on the Rise

Thyroid cancer is on the rise. World-renowned surgeon Orlo Clark, M.D., discusses this trend with Science Cafe.

Read more »
 

Support the Program

A gift to the Section of Endocrine Surgery helps us make advances in the treatment of thyroid cancer and of other endocrine tumors.

Make a Gift »
Endocrine Surgery »  Research »  Clinical Trials

Endocrine Surgery Clinical Trials

   Also show trials not enrolling patients
Select by Type: 

Carcinoid Tumor

RecruitingRecruiting
A Study of Axitinib in Advanced Carcinoid Tumors
Study ID: UCSF-114520
Principal Investigator:
Emily Bergsland, M.D.
Enrolling patients
RecruitingRecruitingNot yet recruitingActive, not recruitingActive, not recruitingRecruitingRecruitingActive, not recruitingRecruitingRecruitingRecruitingRecruitingNot yet recruitingActive, not recruitingRecruitingActive, not recruitingRecruitingRecruitingRecruitingRecruitingRecruitingRecruitingRecruitingRecruitingNot yet recruitingActive, not recruitingActive, not recruitingRecruitingRecruitingActive, not recruitingRecruitingRecruitingRecruitingRecruitingNot yet recruitingActive, not recruitingRecruitingActive, not recruitingRecruitingRecruitingRecruitingRecruiting

Solid Tumor

Recruiting
A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers
Study ID: UCSF-11956
Principal Investigator:
W. Michael Korn, M.D.
Enrolling patients
RecruitingRecruiting
A Study of IMC-CS4 in Subjects With Advanced Solid Tumors
Study ID: UCSF-11993
Principal Investigator:
Hope Rugo, M.D.
Enrolling patients
Recruiting
A Study of LY2875358 in Patients With Advanced Cancer
Study ID: UCSF-109910
Principal Investigator:
Alain Algazi, M.D.
Enrolling patients
Not yet recruiting
A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4
Study ID: UCSF-12955
Principal Investigator:
Hope Rugo, M.D.
Not yet enrolling
Active, not recruitingActive, not recruitingRecruiting
Dose-Escalation Study of GSK2126458
Study ID: UCSF-09992
Principal Investigator:
Pamela Munster, M.D.
Enrolling patients
Recruiting
Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies
Study ID: UCSF-11996
Principal Investigator:
Hope Rugo, M.D.
Enrolling patients
Active, not recruitingRecruiting
MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies
Study ID: UCSF-10998
Principal Investigator:
A. Jo Chien, M.D.
Enrolling patients
Recruiting
Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors
Study ID: UCSF-09991
Principal Investigator:
Pamela Munster, M.D.
Enrolling patients
Recruiting
Phase I Tolerability, Efficacy, and Safety Study of Pazopanib in Combination With PCI-24781 in Patients With Metastatic Solid Tumors
Study ID: UCSF-11955
Principal Investigator:
Pamela Munster, M.D.
Enrolling patients
Recruiting
Phase I/Ib Dose-escalation of Dinaciclib With Weekly Paclitaxel for Advanced Solid Tumor Malignancies & Assessment of MYC Oncogene Overexpression
Study ID: UCSF-12951
Principal Investigator:
A. Jo Chien, M.D.
Enrolling patients
Not yet recruiting
Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors
Study ID: NCT01576666
Principal Investigator:
Pamela Munster, M.D.
Not yet enrolling
Active, not recruitingRecruiting
Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049 AM1)
Study ID: UCSF-11991
Principal Investigator:
Pamela Munster, M.D.
Enrolling patients
Active, not recruitingRecruiting
Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors
Study ID: UCSF-12953
Principal Investigator:
Hope Rugo, M.D.
Enrolling patients
Recruiting
Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma
Study ID: UCSF-11995
Principal Investigator:
Pamela Munster, M.D.
Enrolling patients
Recruiting
Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma
Study ID: UCSF-11954
Principal Investigator:
Pamela Munster, M.D.
Enrolling patients
Recruiting
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
Study ID: UCSF-10993
Principal Investigator:
Pamela Munster, M.D.
Enrolling patients
X